Gene: EI24
Official Full Name: EI24 autophagy associated transmembrane proteinprovided by HGNC
Gene Summary: This gene encodes a putative tumor suppressor and has higher expression in p53-expressing cells than in control cells and is an immediate-early induction target of p53-mediated apoptosis. The encoded protein may suppress cell growth by inducing apoptotic cell death through the caspase 9 and mitochondrial pathways. This gene is located on human chromosome 11q24, a region frequently altered in cancers. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene have been defined on chromosomes 1, 3, 7, and 8. [provided by RefSeq, Feb 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33136 | EI24 Knockout cell line (HeLa) | Human | EI24 | 1:3~1:6 | Negative | Online Inquiry |
KO33137 | EI24 Knockout cell line (HCT 116) | Human | EI24 | 1:2~1:4 | Negative | Online Inquiry |
KO33138 | EI24 Knockout cell line (HEK293) | Human | EI24 | 1:3~1:6 | Negative | Online Inquiry |
KO33139 | EI24 Knockout cell line (A549) | Human | EI24 | 1:3~1:4 | Negative | Online Inquiry |
EI24 Gene Knockout Cell Lines are a sophisticated biological tool designed to study the effects of the EI24 gene, which is implicated in various cellular processes, including autophagy, apoptosis, and tumorigenesis. By utilizing CRISPR-Cas9 technology, these cell lines have been engineered to create precise deletions of the EI24 gene, allowing for the detailed examination of its function and regulation in both physiological and pathological contexts.
The key mechanism of EI24 Gene Knockout Cell Lines involves the double-strand break repair pathway, wherein the CRISPR-Cas9 system induces targeted mutations. This results in the complete loss of EI24 expression. Upon establishment, these knockout cell lines provide invaluable insights into the role of the EI24 gene in different cellular environments, enabling researchers to delineate its contributions to critical cellular mechanisms such as cell cycle regulation and stress response.
Scientific importance lies in their broad applications in molecular and cellular biology research, particularly in cancer studies, where aberrations in gene regulation can lead to malignant transformations. Moreover, the EI24 knockout model can be employed in drug discovery projects focused on developing targeted therapies for cancers associated with dysfunctional autophagy.
What sets EI24 Gene Knockout Cell Lines apart from alternative models is the specificity and efficiency of the CRISPR-Cas9 methodology, ensuring higher fidelity in gene editing and a greater reduction in off-target effects. Additionally, these cell lines provide a robust platform for high-throughput screening, facilitating accelerated research timelines.
For researchers and clinicians, the value of EI24 Gene Knockout Cell Lines cannot be overstated. They offer a unique opportunity to understand the complex roles of the EI24 gene, fostering discoveries that may lead to novel therapeutic strategies. Our company is committed to providing high-quality biological products and solutions, underpinned by cutting-edge technology and comprehensive expertise in gene editing tools, ensuring that our customers have access to the best research resources available.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.